← Back to Search

Behavioural Intervention

Asthma Management App for Asthma

N/A
Recruiting
Led By Robin M Dawson, PhD
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has received a diagnosis of asthma from a health care provider and is taking a controller medication
School-aged (5-18 years) and attends school within the Lancaster County School District
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial aims to make it easier for rural Latino children in SC to take their asthma meds, improving their health.

Who is the study for?
This trial is for Hispanic/Latino or African American children aged 5-18 with asthma, who attend school in Lancaster County School District and are on asthma controller medication. Their parents or caregivers must prefer Spanish or English.Check my eligibility
What is being tested?
The study is testing an mHealth communication intervention using the AsthmaMD mobile app to see if it improves medication adherence among rural Latino children with asthma, compared to usual care without the app.See study design
What are the potential side effects?
Since this trial involves a mobile application for managing asthma and does not include any new medications, there are no direct medical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have asthma and am on medication to control it.
Select...
I am between 5 and 18 years old and go to school in Lancaster County.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Investigate the feasibility of the patient-centered asthma intervention
Mobile app usability and acceptability
Preliminary protocol testing of mobile app-facilitated triadic communication
Secondary outcome measures
Medication adherence and lung function tests

Side effects data

From 2012 Phase 3 trial • 844 Patients • NCT01336205
18%
ABDOMINAL PAIN
14%
DIARRHOEA
10%
NAUSEA
9%
BACK PAIN
9%
HEADACHE
7%
FLATULENCE
6%
ABDOMINAL PAIN UPPER
6%
ARTHRALGIA
6%
BRONCHITIS
6%
NASOPHARYNGITIS
6%
UPPER RESPIRATORY TRACT INFECTION
5%
URINARY TRACT INFECTION
5%
VOMITING
5%
COUGH
4%
FALL
4%
PAIN IN EXTREMITY
4%
SINUSITIS
3%
FATIGUE
3%
PYREXIA
3%
NASAL CONGESTION
3%
MUSCLE SPASMS
3%
HYPERTENSION
3%
GASTROENTERITIS VIRAL
3%
ANXIETY
3%
INSOMNIA
3%
HYPERHIDROSIS
2%
CHILLS
2%
DIZZINESS
2%
ABDOMINAL DISCOMFORT
2%
ABDOMINAL DISTENSION
2%
GASTROOESOPHAGEAL REFLUX DISEASE
2%
OEDEMA PERIPHERAL
2%
CONTUSION
2%
INFLUENZA
2%
DEPRESSION
1%
DEHYDRATION
1%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
1%
HYPERCHOLESTEROLAEMIA
1%
PNEUMONIA
100%
80%
60%
40%
20%
0%
Study treatment Arm
NKTR-118 25 mg
Usual Care

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait list controlExperimental Treatment1 Intervention
Control group with usual care (not using app).
Group II: Patient-centered asthma intervention feasibilityExperimental Treatment1 Intervention
Investigate the effect of the patient-centered asthma intervention using the AsthmaMD app on school days missed and medication adherence.

Find a Location

Who is running the clinical trial?

University of South CarolinaLead Sponsor
211 Previous Clinical Trials
120,429 Total Patients Enrolled
Robin M Dawson, PhDPrincipal InvestigatorUniversity of South Carolina College of Nursing

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
South Carolina
How old are they?
18 - 65
What site did they apply to?
Lancaster County School District
What portion of applicants met pre-screening criteria?
Met criteria
~1 spots leftby Jun 2024